Mannatech, Incorporated(NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2023.
Second Quarter End Results
Second quarter net sales for 2023 were $32.6 million, a decrease of $2.4 million, or 6.8%, as compared to $35.0 million in the second quarter of 2022. Our net sales decreased 4.0% on a constant dollar basis (see Non-GAAP Measures, below) as foreign exchange decreased GAAP net sales by $1.0 million, mostly due to the decline of the Korean Won and Japanese Yen.
Second quarter operating loss for 2023 was $1.0 million as compared to operating income of $0.9 million for the second quarter of 2022.
Net loss was $1.1 million, or $0.59 per diluted share, for the second quarter of 2023, as compared to net income of $0.7 million, or $0.34 per diluted share, for the second quarter of 2022.
For the three months ended June 30, 2023, overall selling and administrative expenses increased by $0.3 million to $7.2 million, as compared to $6.9 million for the same period in 2022. The increase in selling and administrative expenses consisted of a $0.1 million increase in payroll costs (as $0.5 million severance was partially offset by other lower payroll costs), a $0.1 million increase in marketing costs and a $0.1 million increase in warehouse costs.
For the three months ended June 30, 2023, other operating costs increased by $0.6 million to $5.4 million, as compared to $4.9 million for the same period in 2022. The increase in operating costs was primarily due to a $0.4 million increase in consulting fees, a $0.4 million increase in travel and entertainment, which was partially offset by a $0.2 million decrease in office expenses. Consulting fees include $0.4 million in consulting relating to Trulu, a new venture to serve as our innovation hub.
The approximate number of new and continuing independent associate and preferred customer positions held by individuals in Mannatech’s network and associated with purchases of products as of June 30, 2023 and 2022 were approximately 142,000 and 152,000, respectively. Recruitment of new independent associates and preferred customers decreased by 2.59% to 19,309 in the second quarter of 2023 as compared to 19,823 in the second quarter of 2022.
Year-to-date Second Quarter Results
For the six months ended June 30, 2023, net sales were $66.7 million, a decrease of $0.7 million, or 1.0%, as compared to $67.4 million for the same period in 2022. Our net sales increased 2.8% on a constant dollar basis (see Non-GAAP Measures, below) as foreign exchange decreased GAAP net sales by $2.6 million mostly due to the decline of the Korean Won and Japanese Yen.
Operating loss for the six months ended June 30, 2023 was $0.2 million as compared to operating income of $0.9 million for the same period in 2022.
Net loss was $0.5 million, or $0.27 per diluted share, for the six months ended June 30, 2023, as compared to net income of $0.8 million, or $0.40 per diluted share, for the same period in 2022.
We will not pay a quarterly dividend this quarter, which will preserve approximately $0.4 million of cash.
Non-GAAP Measure
In addition to results presented in accordance with GAAP, this press release and related tables include certain non-GAAP financial measures, including a presentation of constant dollar measures. We disclose operating results that have been adjusted to exclude the impact of changes due to the translation of foreign currencies into U.S. dollars, including changes in: Net Sales, Gross Profit, and Income from Operations. We believe that these non-GAAP financial measures provide useful information to investors because they are an indicator of the strength and performance of ongoing business operations. The constant currency figures are financial measures used by management to provide investors an additional perspective on trends. Although we believe the non-GAAP financial measures enhance investors’ understanding of our business and performance, these non-GAAP financial measures should not be considered an exclusive alternative to accompanying GAAP financial measures. Please see the accompanying table entitled "Non-GAAP Financial Measures" for a reconciliation of these non-GAAP financial measures.
Safe Harbor statement
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” “hope,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “potential,” and “continues” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, the impact of COVID-19 on Mannatech’s business, the availability and effectiveness of vaccines on a widespread basis, the impact of any mutations of the COVID-19 virus, the current conflict between Russia and Ukraine, which could adversely affect our business in certain regions, the impact of inflation, disruptions in the supply chain, Mannatech's inability to attract and retain associates and preferred customers, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
Individuals interested in Mannatech's products or in exploring its business opportunity can learn more at Mannatech.com
MANNATECH, INCORPORATED AND SUBSIDIARIES
|
CONSOLIDATED BALANCE SHEETS
|
(in thousands, except share information)
|
|
|
|
|
|
|
|
June 30, 2023
|
|
December 31,
|
ASSETS
|
|
(unaudited)
|
|
2022
|
Cash and cash equivalents
|
|
$
|
9,374
|
|
|
$
|
13,777
|
|
Restricted cash
|
|
|
938
|
|
|
|
944
|
|
Accounts receivable, net of allowance of $1,109 and $973 in 2023 and 2022, respectively
|
|
|
645
|
|
|
|
218
|
|
Income tax receivable
|
|
|
422
|
|
|
|
423
|
|
Inventories, net
|
|
|
15,838
|
|
|
|
14,726
|
|
Prepaid expenses and other current assets
|
|
|
2,183
|
|
|
|
2,389
|
|
Deferred commissions
|
|
|
1,852
|
|
|
|
2,476
|
|
Total current assets
|
|
|
31,252
|
|
|
|
34,953
|
|
Property and equipment, net
|
|
|
4,689
|
|
|
|
3,759
|
|
Long-term restricted cash
|
|
|
460
|
|
|
|
476
|
|
Other assets
|
|
|
7,834
|
|
|
|
8,439
|
|
Deferred tax assets, net
|
|
|
1,164
|
|
|
|
1,501
|
|
Total assets
|
|
$
|
45,399
|
|
|
$
|
49,128
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
Current portion of finance leases
|
|
$
|
274
|
|
|
$
|
61
|
|
Accounts payable
|
|
|
5,825
|
|
|
|
4,361
|
|
Accrued expenses
|
|
|
6,930
|
|
|
|
7,510
|
|
Commissions and incentives payable
|
|
|
8,734
|
|
|
|
9,256
|
|
Taxes payable
|
|
|
1,738
|
|
|
|
3,281
|
|
Current notes payable
|
|
|
411
|
|
|
|
263
|
|
Deferred revenue
|
|
|
4,330
|
|
|
|
5,106
|
|
Total current liabilities
|
|
|
28,242
|
|
|
|
29,838
|
|
Finance leases, excluding current portion
|
|
|
1,115
|
|
|
|
88
|
|
Other long-term liabilities
|
|
|
4,400
|
|
|
|
5,026
|
|
Total liabilities
|
|
|
33,757
|
|
|
|
34,952
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
Shareholders’ equity:
|
|
|
|
|
Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding
|
|
|
—
|
|
|
|
—
|
|
Common stock, $0.0001 par value, 99,000,000 shares authorized, 2,742,857 shares issued and 1,866,212 shares outstanding as of June 30, 2023 and 2,742,857 shares issued and 1,858,800 shares outstanding as of December 31, 2022
|
|
|
—
|
|
|
|
—
|
|
Additional paid-in capital
|
|
|
33,294
|
|
|
|
33,377
|
|
Retained earnings
|
|
|
437
|
|
|
|
1,686
|
|
Accumulated other comprehensive (loss) income
|
|
|
(1,658
|
)
|
|
|
(208
|
)
|
Treasury stock, at average cost, 876,645 shares as of June 30, 2023 and 884,057 shares as of December 31, 2022
|
|
|
(20,431
|
)
|
|
|
(20,679
|
)
|
Total shareholders’ equity
|
|
|
11,642
|
|
|
|
14,176
|
|
Total liabilities and shareholders’ equity
|
|
$
|
45,399
|
|
|
$
|
49,128
|
|
MANNATECH, INCORPORATED AND SUBSIDIARIES
|
CONSOLIDATED STATEMENTS OF OPERATIONS
|
(in thousands, except per share information)
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
|
|
June 30,
|
|
June 30,
|
|
|
2023
|
|
2022
|
|
2023
|
|
2022
|
Net sales
|
|
$
|
32,594
|
|
|
$
|
34,976
|
|
|
$
|
66,708
|
|
|
$
|
67,360
|
|
Cost of sales
|
|
|
7,004
|
|
|
|
7,920
|
|
|
|
14,417
|
|
|
|
15,011
|
|
Gross profit
|
|
|
25,590
|
|
|
|
27,056
|
|
|
|
52,291
|
|
|
|
52,349
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
Commissions and incentives
|
|
|
13,465
|
|
|
|
14,137
|
|
|
|
27,022
|
|
|
|
27,245
|
|
Selling and administrative expenses
|
|
|
7,257
|
|
|
|
6,914
|
|
|
|
13,673
|
|
|
|
13,823
|
|
Depreciation and amortization expense
|
|
|
387
|
|
|
|
301
|
|
|
|
774
|
|
|
|
633
|
|
Other operating costs
|
|
|
5,435
|
|
|
|
4,851
|
|
|
|
11,063
|
|
|
|
9,760
|
|
Total operating expenses
|
|
|
26,544
|
|
|
|
26,203
|
|
|
|
52,532
|
|
|
|
51,461
|
|
(Loss) income from operations
|
|
|
(954
|
)
|
|
|
853
|
|
|
|
(241
|
)
|
|
|
888
|
|
Interest (expense) income, net
|
|
|
(10
|
)
|
|
|
23
|
|
|
|
14
|
|
|
|
38
|
|
Other income (expense), net
|
|
|
150
|
|
|
|
(84
|
)
|
|
|
483
|
|
|
|
1
|
|
(Loss) income before income taxes
|
|
|
(814
|
)
|
|
|
792
|
|
|
|
256
|
|
|
|
927
|
|
Income tax (provision)
|
|
|
(291
|
)
|
|
|
(98
|
)
|
|
|
(757
|
)
|
|
|
(99
|
)
|
Net (loss) income
|
|
$
|
(1,105
|
)
|
|
$
|
694
|
|
|
$
|
(501
|
)
|
|
$
|
828
|
|
(Loss) income per common share:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.59
|
)
|
|
$
|
0.36
|
|
|
$
|
(0.27
|
)
|
|
$
|
0.43
|
|
Diluted
|
|
$
|
(0.59
|
)
|
|
$
|
0.34
|
|
|
$
|
(0.27
|
)
|
|
$
|
0.40
|
|
Weighted-average common shares outstanding:
|
|
|
|
|
|
|
|
|
Basic
|
|
|
1,870
|
|
|
|
1,942
|
|
|
|
1,871
|
|
|
|
1,944
|
|
Diluted
|
|
|
1,870
|
|
|
|
2,031
|
|
|
|
1,871
|
|
|
|
2,052
|
|
Non-GAAP Financial Measures (Sales, Gross Profit and Income from Operations in Constant Dollars)
To supplement our financial results presented in accordance with generally accepted accounting principles in the United States (“GAAP”), we disclose operating results that have been adjusted to exclude the impact of changes due to the translation of foreign currencies into U.S. dollars, including changes in: Net Sales, Gross Profit, and Income from Operations. We refer to these adjusted financial measures as constant dollar items, which are non-GAAP financial measures. We believe these measures provide investors an additional perspective on trends. To exclude the impact of changes due to the translation of foreign currencies into U.S. dollars, we calculate current year results and prior year results at a constant exchange rate, which is the prior year’s rate. Currency impact is determined as the difference between actual growth rates and constant currency growth rates.
The table below reconciles second quarter 2023 and year-to-date constant dollar net sales, gross profit and income from operations to our GAAP net sales, gross profit and income from operations.
Three-month period ended
|
|
June 30, 2023
|
|
June 30, 2022
|
|
Constant $ Change
|
(in millions, except percentages)
|
|
GAAP
|
|
Non-GAAP
|
|
GAAP
|
|
|
|
|
|
|
Measure:
|
|
Measure:
|
|
Measure:
|
|
|
|
|
|
|
Total $
|
|
Constant $
|
|
Total $
|
|
Dollar
|
|
Percent
|
Net sales
|
|
$
|
32.6
|
|
|
$
|
33.6
|
|
|
$
|
35.0
|
|
$
|
(1.4
|
)
|
|
(4.0
|
)%
|
Product
|
|
|
31.0
|
|
|
|
32.0
|
|
|
|
33.0
|
|
|
(1.0
|
)
|
|
(3.0
|
)%
|
Pack sales and associate fees
|
|
|
1.4
|
|
|
|
1.4
|
|
|
|
1.8
|
|
|
(0.4
|
)
|
|
(22.2
|
)%
|
Other
|
|
|
0.2
|
|
|
|
0.2
|
|
|
|
0.2
|
|
|
—
|
|
|
—
|
%
|
Gross profit
|
|
|
25.6
|
|
|
|
26.4
|
|
|
|
27.1
|
|
|
(0.7
|
)
|
|
(2.6
|
)%
|
(Loss) income from operations
|
|
|
(1.0
|
)
|
|
|
(0.8
|
)
|
|
|
0.9
|
|
|
(1.7
|
)
|
|
(188.9
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six-month period ended
|
|
June 30, 2023
|
|
June 30, 2022
|
|
Constant $ Change
|
(in millions, except percentages)
|
|
GAAP
|
|
Non-GAAP
|
|
GAAP
|
|
|
|
|
|
|
Measure:
|
|
Measure:
|
|
Measure:
|
|
|
|
|
|
|
Total $
|
|
Constant $
|
|
Total $
|
|
Dollar
|
|
Percent
|
Net sales
|
|
$
|
66.7
|
|
|
$
|
69.3
|
|
|
$
|
67.4
|
|
$
|
1.9
|
|
|
2.8
|
%
|
Product
|
|
|
62.9
|
|
|
|
65.3
|
|
|
|
63.8
|
|
|
1.5
|
|
|
2.4
|
%
|
Pack sales and associate fees
|
|
|
3.5
|
|
|
|
3.7
|
|
|
|
3.1
|
|
|
0.6
|
|
|
19.4
|
%
|
Other
|
|
|
0.3
|
|
|
|
0.3
|
|
|
|
0.5
|
|
|
(0.2
|
)
|
|
(40.0
|
)%
|
Gross profit
|
|
|
52.3
|
|
|
|
54.3
|
|
|
|
52.3
|
|
|
2.0
|
|
|
3.8
|
%
|
(Loss) income from operations
|
|
|
(0.2
|
)
|
|
|
0.3
|
|
|
|
0.9
|
|
|
(0.6
|
)
|
|
(66.7
|
)%
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20230814475245/en/